
Company valuation, historical trends, and peer comparisons.
According to Veru Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 14.97M. This represents a change of -54.12% compared to the average of 32.62M of the last 4 quarters.
The mean historical Enterprise Value of Veru Inc. over the last ten years is 211.93M. The current 14.97M Enterprise Value has changed -92.94% with respect to the historical average. Over the past ten years (40 quarters), VERU's Enterprise Value was at its highest in in the March 2021 quarter at 7.98B. The Enterprise Value was at its lowest in in the December 2025 quarter at 13.45M.
Average
211.93M
Median
90.59M
Minimum
32.59M
Maximum
858.70M
Discovering the peaks and valleys of Veru Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 208.93%
Maximum Annual Enterprise Value = 858.70M
Minimum Annual Increase = -92.33%
Minimum Annual Enterprise Value = 32.59M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 42.98M | -53.62% |
| 2024 | 92.67M | 40.67% |
| 2023 | 65.88M | -92.33% |
| 2022 | 858.70M | 58.43% |
| 2021 | 541.99M | 208.93% |
| 2020 | 175.44M | 23.03% |
| 2019 | 142.60M | 82.94% |
| 2018 | 77.95M | -11.94% |
| 2017 | 88.52M | 171.63% |
| 2016 | 32.59M | -20.47% |
The current Enterprise Value of Veru Inc. (VERU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
67.17M
5-year avg
320.44M
10-year avg
211.93M
Veru Inc.’s Enterprise Value is less than BioXcel Therapeutics, Inc. (0), less than Annovis Bio, Inc. (32.27M), less than Celularity Inc. (62.06M), less than PolyPid Ltd. (103.88M), greater than BioAtla, Inc. (7.20M), greater than Reviva Pharmaceuticals Holdings, Inc. (-19745862663743.00), less than MAIA Biotechnology, Inc. (42.17M), less than Dyadic International, Inc. (19.14M), less than RenovoRx, Inc. (47.64M), greater than Mural Oncology plc (-19941249.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 0 | $2.28M | |
| 32.27M | $51.00M | |
| 62.06M | $26.63M | |
| 103.88M | $108.87M | |
| 7.20M | $2.88M | |
| -19745862663743.00 | $4.34M | |
| 42.17M | $69.77M | |
| 19.14M | $15.52M | |
| 47.64M | $56.86M | |
| -19941249.00 | $35.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Veru Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Veru Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Veru Inc.'s Enterprise Value?
What is the highest Enterprise Value for Veru Inc. (VERU)?
What is the 3-year average Enterprise Value for Veru Inc. (VERU)?
What is the 5-year average Enterprise Value for Veru Inc. (VERU)?
How does the current Enterprise Value for Veru Inc. (VERU) compare to its historical average?